Green-synthesized silver nanoparticles as plasmonic redox catalysts: Linking charge transfer to antibacterial and dye degradation activities
Materials Today Communications · 2026-12 · 57 · 115708
DOI: 10.1016/j.mtcomm.2026.115708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Communications, 2026-12. Verfasst von Tamilselvan Amutha Gokul und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tamilnadu State Council For Science And Technology, National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Tamilnadu State Council For Science And Technology
- National Science and Technology Council
Zitieren
APA
Gokul, T. A., Kumar, K. R., Ali, D., Barros, A. L. B. D., Dang, K. D., Veeramanikandan, V., Pothiraj, C., Nguyen, V., Huang, C., & Balaji, P. (2026). Green-synthesized silver nanoparticles as plasmonic redox catalysts: Linking charge transfer to antibacterial and dye degradation activities. Materials Today Communications, 57, 115708. https://doi.org/10.1016/j.mtcomm.2026.115708
Vancouver
Gokul TA, Kumar KR, Ali D, Barros ALBD, Dang KD, Veeramanikandan V, et al. Green-synthesized silver nanoparticles as plasmonic redox catalysts: Linking charge transfer to antibacterial and dye degradation activities. Materials Today Communications. 2026;57:115708. doi:10.1016/j.mtcomm.2026.115708
BibTeX
@article{Gokul2026,
author = {Gokul, Tamilselvan Amutha and Kumar, Kamatchi Ramesh and Ali, Daoud and Barros, André Luis Branco de and Dang, Khoa Dang and Veeramanikandan, Veeramani and Pothiraj, Chinnathambi and Nguyen, Van-Huy and Huang, Chao-Wei and Balaji, Paulraj},
title = {Green-synthesized silver nanoparticles as plasmonic redox catalysts: Linking charge transfer to antibacterial and dye degradation activities},
journal = {Materials Today Communications},
year = {2026},
volume = {57},
pages = {115708},
doi = {10.1016/j.mtcomm.2026.115708}
}
EUVIMED